menu
    • menu

    Company profile for Myrtelle

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Myrtelle is a patient-centered, innovation-driven gene therapy company transforming the treatment of neurological diseases. Our mission is to develop and deliver novel treatments for devastating disorders of the central nervous system for which few, if any, treatment options exist. We envision a world in which patients with rare CNS diseases can access treatments that improve their quality of life & longevity.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    MyrtelleUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    301 Edgewater Place Suite 330 Wakefield, MA 01880
    Telephone
    Telephone
    781-245-0715
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://myrtellegtx.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Myrtelle Share Interim Ph1/2 Gene Therapy Data In Canavan Disease
    Myrtelle Share Interim Ph1/2 Gene Therapy Data In Canavan Disease

    06 Oct 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myrtelle-announces-presentation-of-encouraging-interim-results-from-its-phase-12-gene-therapy-trial-for-canavan-disease-at-the-2025-cell--gene-meeting-on-the-mesa-302575461.html

    PR NEWSWIRE
    06 Oct 2025
    Share Share
    Myrtelle Publishes Interim Phase 1/2 Results of rAAV-Olig001-ASPA
    Myrtelle Publishes Interim Phase 1/2 Results of rAAV-Olig001-ASPA

    01 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/01/3159494/0/en/Myrtelle-Announces-Nature-Medicine-Publication-of-Interim-Results-from-Its-Phase-1-2-Clinical-Trial-of-Investigational-Gene-Therapy-rAAV-Olig001-ASPA-for-Canavan-Disease.html

    GLOBENEWSWIRE
    01 Oct 2025
    Share Share
    Myrtelle Publishes Interim Ph 1/2 rAAV-Olig001-ASPA Data
    Myrtelle Publishes Interim Ph 1/2 rAAV-Olig001-ASPA Data

    16 Sep 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myrtelle-announces-nature-medicine-publication-of-interim-results-from-its-phase-12-clinical-trial-of-investigational-gene-therapy-raav-olig001-aspa-for-canavan-disease-302557585.html

    PR NEWSWIRE
    16 Sep 2025
    Share Share
    Myrtelle, Charles River, Viralgen Team on Canavan Therapy
    Myrtelle, Charles River, Viralgen Team on Canavan Therapy

    09 Jul 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myrtelle-launches-manufacturing-of-first-in-class-gene-therapy-for-canavan-disease-in-strategic-alliance-with-charles-river-and-viralgen-302499029.html

    PR NEWSWIRE
    09 Jul 2025
    Share Share
    Myrtelle to Present Insights on FDA's START at ASGCT 2025
    Myrtelle to Present Insights on FDA's START at ASGCT 2025

    13 May 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/myrtelle-to-present-breakthrough-insights-on-fdas-groundbreaking-start-pilot-program-at-the-american-society-of-gene-and-cell-therapy-asgct-2025-annual-meeting-in-new-orleans-on-thursday-may-15th-302451777.html

    PR NEWSWIRE
    13 May 2025
    Share Share
    Myrtelle Reports NAA Reduction In Canavan Disease Gene Therapy
    Myrtelle Reports NAA Reduction In Canavan Disease Gene Therapy

    10 Oct 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241010688273/en

    BUSINESSWIRE
    10 Oct 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search